Trials / Conditions / Appendix Adenocarcinoma
Appendix Adenocarcinoma
3 registered clinical trials studyying Appendix Adenocarcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Genetics of Appendix Cancer Study NCT05734430 | Andreana Holowatyj, PhD, MSCI | — |
| Completed | Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors NCT03108131 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors NCT03074513 | M.D. Anderson Cancer Center | Phase 2 |